If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> CARDIOLOGY<br /> AHA supplement • emjreviews.com<br /> INSIDE<br /> Review of the<br /> AHA Congress<br /> Dallas, Texas<br /> European Medical Journal<br /> Cardiology Supplement<br /> January 2014<br /> Publisher<br /> Claire Gore<br /> Editor<br /> John Oliver<br /> Editorial Assistants<br /> Kelly Rose Llewellyn<br /> Joanne Rajroop<br /> Production Assistant<br /> Rebecca Diggins<br /> Medical Journalist<br /> Daniel Bone<br /> Director<br /> Spencer Gore<br /> Project Director<br /> Daniel Healy<br /> Project Manager<br /> Katie White<br /> Product Development<br /> Manager<br /> Zoë Webster<br /> Marketing and Circulation<br /> Emma Baxter<br /> Personal Assistant<br /> Aimee Flack<br /> www.emjreviews.com<br /> 31-34 Railway Street<br /> Chelmsford<br /> Essex, UK<br /> CM1 1QS<br /> 2<br /> AHA CONGRESS 2013<br /> DALLAS CONVENTION CENTER<br /> DALLAS, TEXAS, USA<br /> 16TH-20TH NOVEMBER 2013<br /> Welcome to the Europea<a title="EMJ Cardiol. 2013 Suppl 1 page 1" href="http://viewer.zmags.com/publication/9ce5c4ab?page=1"> CARDIOLOGY AHA supplement • emjreviews.com INS</a> <a title="EMJ Cardiol. 2013 Suppl 1 page 2" href="http://viewer.zmags.com/publication/9ce5c4ab?page=2"> European Medical Journal Cardiology Supplement Ja</a> <a title="EMJ Cardiol. 2013 Suppl 1 page 3" href="http://viewer.zmags.com/publication/9ce5c4ab?page=3"> “Practice guidelines recommend repairing or repla</a> <a title="EMJ Cardiol. 2013 Suppl 1 page 4" href="http://viewer.zmags.com/publication/9ce5c4ab?page=4"> AHA CONGRESS 2013 DALLAS CONVENTION CENTER DALLAS</a> <a title="EMJ Cardiol. 2013 Suppl 1 page 5" href="http://viewer.zmags.com/publication/9ce5c4ab?page=5"> University of California, Irvine, USA, said:</a> <a title="EMJ Cardiol. 2013 Suppl 1 page 6" href="http://viewer.zmags.com/publication/9ce5c4ab?page=6"> EFFECTIVE ANTICOAGULATION WITH FACTOR XA NEXT </a> <a title="EMJ Cardiol. 2013 Suppl 1 page 7" href="http://viewer.zmags.com/publication/9ce5c4ab?page=7"> Of the patients enrolled in the trial, 99.6% rece</a> <a title="EMJ Cardiol. 2013 Suppl 1 page 8" href="http://viewer.zmags.com/publication/9ce5c4ab?page=8"> NOVEL ANTICOAGULANTS IN ATRIAL FIBRILLATION Summa</a> <a title="EMJ Cardiol. 2013 Suppl 1 page 9" href="http://viewer.zmags.com/publication/9ce5c4ab?page=9"> However, there was an increased risk of ma</a> <a title="EMJ Cardiol. 2013 Suppl 1 page 10" href="http://viewer.zmags.com/publication/9ce5c4ab?page=10"> mortality, and the principal safety outcome was m</a> <a title="EMJ Cardiol. 2013 Suppl 1 page 11" href="http://viewer.zmags.com/publication/9ce5c4ab?page=11"> Dr Ruff concluded that NOACs offer an effective a</a> <a title="EMJ Cardiol. 2013 Suppl 1 page 12" href="http://viewer.zmags.com/publication/9ce5c4ab?page=12"> EVERY PATIENT IS DIFFERENT. ORAL ANTICOAGULANTS N</a>